Improved understanding of disease microbes can help develop new  treatment options. H. pylori are  pathogenic bacteria that cause a variety of diseases. Ace Therapeutics provides basic and supporting research services for H. pylori to help study the relationship between H. pylori and its  pathogenicity. These basic and supporting studies can help to find solutions  for the realization of vaccines and therapeutic drugs against H. pylori.
  Current status of H. pylori research
  The  improvement of sequencing technology and the detection capability of various  testing devices have accelerated the research on H. pylori.  From the discovery of H. pylori to the  present, the basic situation of H. pylori has been  well studied, including the structure and morphology of H. pylori, culture conditions, the  distribution of different populations, the evolution of different populations  and the types of diseases caused by H. pylori. In  addition, the more in-depth studies of H. pylori have been  well developed, including survival mechanisms,  colonization mechanisms, pathogenic mechanisms, drug resistance mechanisms and immune evasion mechanisms. These studies have deepened our  understanding of H. pylori. However, there is still a  need for more studies of H. pylori to aid in  the development of H. pylori vaccines  and drugs.
  
 Fig. 1 In-depth study of H. pylori.
Fig. 1 In-depth study of H. pylori.
  Our services
  Ace Therapeutics  helps explore the uncharted territory of H. pylori and  provides basic and supporting services to help study H. pylori.  We focus on basic research that can provide reference solutions for the  treatment of H. pylori and this is clearly reflected  in our services.
  Studies on the membrane proteins of H. pylori
  The outer  membrane proteins of H. pylori, especially  the adhesins, are associated with H. pylori survival,  colonization, pathogenicity and antibiotic resistance. Ace Therapeutics provides  research services related to the outer membrane proteins of H. pylori to help discover new therapeutic targets. And we focused more on the study of H. pylori adhesins.
  Associations between genetic polymorphisms and  gastrointestinal diseases
  Genetic  polymorphisms in H. pylori and humans have effects on  the types of disease caused by H. pylori, but some  specific effects remain to be explored. We offer services to explore the  relationship between genetic polymorphisms and diseases caused by H. pylori to assist in the study of pathogenic mechanisms.
  Studies on H. pylori outer  membrane vesicles
  The outer membrane vesicles of H. pylori can carry outer membrane proteins and virulence  factors. And their production facilitates biofilm formation. These have an  impact on the pathogenicity of H. pylori and may  influence the choice of treatment options for H. pylori.  We offer services to help further study H. pylori outer membrane vesicles to help address questions related to the impact of outer  membrane vesicles on disease.
  Studies on the integrative and conjugative elements of H. pylori
  Integrative and conjugative  elements are genetically important variable regions of H. pylori and have been found to be associated with pathogenicity of H. pylori.  To this end, we offer three types of services to further help investigate the  relationship between integrative and conjugative elements and pathogenicity.
  Note:
  The specific service content and strengths of our services are  displayed on the service details page. You can click to view.
Collaborate with us
  H.  pylori are associated with more than 50% of the  world's population and is one of the global concerns. Ace Therapeutics specializes in H. pylori and has a deep understanding  of H. pylori. We have the ability to help our  clients achieve a deeper exploration of H. pylori and further  explore the mechanisms involved in the disease caused by H. pylori.  We call on you to work with us to help solve the worldwide problem of H. pylori.
                        ※ All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.